Skip to main navigation
Skip to search
Skip to main content
Albert Einstein College of Medicine Home
Home
Faculty
Departments
Grants
Publications
Prizes
Search by expertise, name or affiliation
Prophylactic HPV vaccination: Past, present, and future
P. E. Castle
, M. Maza
Epidemiology & Population Health
Research output
:
Contribution to journal
›
Review article
›
peer-review
152
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Prophylactic HPV vaccination: Past, present, and future'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Human Papillomavirus Vaccine
100%
Human Papillomavirus Genotypes
100%
Futures Past
100%
Past-present
100%
High-risk Human Papillomavirus (HR-HPV)
80%
Cervical Cancer
80%
HPV18
40%
HPV16
40%
U.S. Food
40%
Young Female
40%
Cost-effectiveness
40%
HPV6
40%
HPV11
40%
Cancer Mortality
20%
Cancer Causes
20%
Clinical Trials
20%
High-risk Population
20%
Common Cause
20%
Safety Profile
20%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
20%
Preventing Infection
20%
Adolescent Males
20%
Virus-like
20%
Anal Cancer
20%
Sexually Active
20%
Next-generation Vaccines
20%
Common Cancers
20%
Female-to-male
20%
Young Adolescents
20%
Adolescent Women
20%
Population Prevalence
20%
Low-middle Income Countries
20%
Vulvar Cancer
20%
Penile Cancer
20%
Sufficient Cause
20%
Global Health Priorities
20%
Adolescent Females
20%
Vaginal Cancer
20%
Mandatory Vaccines
20%
Genital Warts
20%
Herd Protection
20%
Heterosexual Men
20%
Anogenital Disease
20%
Pharmacology, Toxicology and Pharmaceutical Science
Vaccination Policy
100%
Human Papillomavirus
100%
Uterine Cervix Cancer
30%
Malignant Neoplasm
23%
Disease
23%
Infection
15%
Human Papillomavirus Type 16
15%
Human Papillomavirus Type 18
15%
Human Papillomavirus Type 6
15%
Human Papillomavirus Type 11
15%
Wart Virus Vaccine
7%
Prevalence
7%
Clinical Trial
7%
Oropharynx Cancer
7%
Anus Cancer
7%
Vagina Cancer
7%
Virus Like Agent
7%
Condyloma acuminatum
7%
Penis Cancer
7%
Medicine and Dentistry
Herd
7%